HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nathan V Lee Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

9/2013Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nathan V Lee Research Topics

Disease

12Neoplasms (Cancer)
01/2019 - 11/2011
2Breast Neoplasms (Breast Cancer)
01/2019 - 09/2012
2Colorectal Neoplasms (Colorectal Cancer)
11/2014 - 01/2013
1Mouth Neoplasms (Oral Cancer)
09/2016
1Neuroblastoma
01/2016
1Acquired Immunodeficiency Syndrome (AIDS)
09/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2013
1Neoplasm Metastasis (Metastasis)
09/2012
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2012
1Retinoblastoma (Glioblastoma, Retinal)
03/2012
1Colonic Neoplasms (Colon Cancer)
03/2012
1Stomach Neoplasms (Stomach Cancer)
01/2012
1Carcinoma (Carcinomatosis)
11/2011

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
11/2014 - 11/2011
3Biomarkers (Surrogate Marker)IBA
12/2013 - 03/2012
2palbociclibIBA
01/2019 - 10/2016
2Anaplastic Lymphoma KinaseIBA
01/2016 - 09/2013
2CrizotinibIBA
01/2016 - 09/2013
22- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA
01/2012 - 11/2011
1CarbonIBA
01/2019
1Fulvestrant (Faslodex)FDA Link
01/2019
1ribociclibIBA
10/2016
1dinaciclibIBA
10/2016
1N- ((5- (3- (4,6- difluoro- 1H- benzimidazol- 2- yl)- 1H- indazol- 5- yl)- 4- methylpyridin- 3- yl)methyl)ethanamineIBA
10/2016
1abemaciclibIBA
10/2016
1Adenosine Triphosphate (ATP)IBA
10/2016
1Oxygen (Dioxygen)IBA
09/2016
1Free RadicalsIBA
09/2016
11-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2016
1lorlatinibIBA
01/2016
1Transcription Factors (Transcription Factor)IBA
11/2014
1dacomitinibIBA
11/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2014
12- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA
11/2014
1Sirolimus (Rapamycin)FDA Link
11/2014
1Insulin-Like PeptidesIBA
12/2013
1Insulin-Like Growth Factor Binding Protein 5IBA
12/2013
1Insulin Receptor Substrate ProteinsIBA
12/2013
1figitumumabIBA
12/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2013
1PF 3758309IBA
01/2013
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2013
1Messenger RNA (mRNA)IBA
09/2012
1nirogacestatIBA
09/2012
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
09/2012
1Aurora Kinase BIBA
03/2012
1Aurora Kinase AIBA
03/2012
1N- (2- (6- (4- cyclobutylamino- 5- trifluoromethylpyrimidine- 2- ylamino)- 1,2,3,4- tetrahydro- 1,4- epiazano- naphthalen- 9- yl)- 2- oxo- ethyl)acetamideIBA
03/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2012
1Proto-Oncogene Proteins c-metIBA
01/2012
1Tyrosine Kinase InhibitorsIBA
01/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2011

Therapy/Procedure

3Therapeutics
01/2019 - 11/2014
1Photochemotherapy (Photodynamic Therapy)
09/2016
1Semiconductors
09/2013
1Aftercare (After-Treatment)
09/2012